SCHEMBL3516211

SCHEMBL3516211

CCN(C(=O)c1cccc(Oc2cc(C(O)Cc3cncn3C)ccc2C#N)c1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FNTA P49354 14/20 0.45
FNTB P49356 14/20 0.45
PGGT1B P53609 13/20 0.45
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3518848 0.92 FNTA (0.45) FNTAFNTBPGGT1BHTT
SCHEMBL8125823 0.88 FNTA (0.53) FNTAFNTBPGGT1B
SCHEMBL3516596 0.86 FNTA (0.49) FNTAFNTBPGGT1B
SCHEMBL3516212 0.86 FNTA (0.47) FNTAFNTBPGGT1BHTT
SCHEMBL5552065 0.85 FNTA (0.46) FNTAFNTBPGGT1B
SCHEMBL3518853 0.81 FNTA (0.46) FNTAFNTBPGGT1BHTT
SCHEMBL5548775 0.81 FNTA (0.51) FNTAFNTBPGGT1B
SCHEMBL3520386 0.80 PGGT1B (0.48) FNTAFNTBPGGT1B
SCHEMBL5552177 0.80 FNTA (0.51) FNTAFNTBPGGT1B
SCHEMBL3504226 0.79 FNTA (0.57) FNTAFNTBPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1744751-A2 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2007-01-24 EP claimed
WO-2005089502-A2 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2005-09-29 WO claimed
EP-2155197-A2 TREATMENT OF LYSOSOMAL STORAGE DISEASES Link Medicine Corporation (US) 2010-02-24 EP disclosed
WO-2008112525-A2 TREATMENT OF LYSOSOMAL STORAGE DISEASES LINK MEDICINE CORPORATION (US) 2008-09-18 WO disclosed